EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice - Archive ouverte HAL Access content directly
Journal Articles European Respiratory Journal Year : 2017

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

Marie Wislez
  • Function : Author
  • PersonId : 989590

Dates and versions

hal-01699297 , version 1 (02-02-2018)

Identifiers

Cite

Pascale Tomasini, Solenn Brosseau, Julien Mazières, Jean Merlio, Michèle Beau-Faller, et al.. EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice. European Respiratory Journal, 2017, 50 (2), pii: 1700514. ⟨10.1183/13993003.00514-2017⟩. ⟨hal-01699297⟩
190 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More